Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
The author states there is electronic patient access for those of
EMIS practices. Untrue, those of us persuaded to buy the flagship product
of Emis namely PCS, are still waiting for our patients to be able to order
prescriptions online, let alone view their records. PCS cannot use GP2GP
yet either so we are stuck in the dark age of typing in full medical
history, results medicines etc etc from a printout of electronic notes
when a patient moves practice. Enourmously time consuming. We are (still)
waiting for the next Emis product Emis web. Things are not as joined up as
Brian suggests.
Access-not yet
The author states there is electronic patient access for those of
EMIS practices. Untrue, those of us persuaded to buy the flagship product
of Emis namely PCS, are still waiting for our patients to be able to order
prescriptions online, let alone view their records. PCS cannot use GP2GP
yet either so we are stuck in the dark age of typing in full medical
history, results medicines etc etc from a printout of electronic notes
when a patient moves practice. Enourmously time consuming. We are (still)
waiting for the next Emis product Emis web. Things are not as joined up as
Brian suggests.
Competing interests:
None declared
Competing interests: No competing interests